Molecular epidemiology of the expression of urokinase plasminogen activator receptor-associated protein (uPARAP) in mesenchymal malignancies. [PDF]
Wang CC +11 more
europepmc +1 more source
Hybrid macrocyclic peptides unite genetically encoded peptide libraries with the structural complexity of synthetic small molecules. This Review critically analyzes phage‐compatible cyclization and diversification chemistries, highlights emerging opportunities beyond traditional cysteine‐based approaches, and outlines how future advances may enable the
Titia Rixt Oppewal, Clemens Mayer
wiley +1 more source
Inhibition of Plasminogen Activator Inhibitor-1 (PAI-1) by Tiplaxtinin Attenuates the Aggressive Phenotype of Vulvar Squamous Cell Carcinoma Cells <i>In Vitro</i>. [PDF]
Warmbold J, Gallwas J, Gründker C.
europepmc +1 more source
Soluble urokinase plasminogen activator receptor and perioperative complications: a systematic review. [PDF]
Gungor AB +4 more
europepmc +1 more source
Soluble urokinase plasminogen activator receptor is a prognostic biomarker in decompensated cirrhosis. [PDF]
Lamatsch S +25 more
europepmc +1 more source
Modeling the role of urokinase-type plasminogen activator, uPA, and circulating cancer-associated fibroblasts (cCAFs) in breast cancer cell extravasation. [PDF]
Spartz A +5 more
europepmc +1 more source
Placental plasminogen activator inhibitor 1 is induced by platelet-derived TGF-β independently of TGF-β receptor 3 and is upregulated in preeclampsia. [PDF]
Forstner D +15 more
europepmc +1 more source
Differentiating borderline HER2-expressing and HER2-positive cancers from other subtypes using serum urokinase plasminogen activator. [PDF]
López Mujica MEJ +6 more
europepmc +1 more source
Mechanical Aortic Valve Thrombosis: Treatment With Tissue Plasminogen Activator. [PDF]
Munawar G, Gupta V, Laiq Z, Sleik K.
europepmc +1 more source

